@realDonaldTrump @RepJodeyArrington @SenTedCruz@JohnCornyn
The Senate squeaked through that CR 60–40, which at least gets the government funded through January, pays 750,000+ federal workers what they’re owed, and tees up an ACA vote in December. Great. Necessary. But let’s not act like anyone solved world peace here.
We’ve been shut down for 42 days. Airports are still cutting flights. The economy took a hit. I appreciate the effort… but this is not the moment to pat ourselves on the back.
The real fight is the LOWER PREMIUMS ACT. Families can’t keep swallowing $27,000 annual premiums (KFF 2026 numbers). That’s a 26% jump! It’s ridiculous. We need real reform: HSAs that matter, interstate insurance options, tort reform—the stuff that actually lowers costs instead of stuffing corporate pockets. Put it to a House vote by Nov. 19 and Senate by Nov. 25. No more dragging feet.
And that ACA credit vote in December? Don’t extend anything unless it comes with market-based fixes. If leadership won’t push for real change, then they shouldn’t be surprised when primary challengers start looking real attractive.
@JulissaGarzaTv@hollyshansen I got in line at 2pm & finally got through security at 6:45pm today at IAH. Terminals A & E were the only ones open. Standard screening only, precheck/clear closed. Missed my first flight & had to rebook while in line.
I completely agree that the cost of tuition is ridiculous! But! The paying for college mindset has done a complete 180. Comparatively speaking, college was expensive 30 years ago, too. People went wherever they could afford to go. And, they got student loans when needed. But, they were smart enough to get loans just for tuition & books. A job paid for living expenses. Now, students are told that it’s impossible to work while you’re in college. And, they borrow money to pay for everything. Banks are happy to hand it out! No, it’s not impossible to work & go to college at the same time. In fact, with online classes as an option, it’s easier today to do both. I do understand if you are in law school, medical school, nursing school, etc, that you may not be able to work at the same time, but you can with most undergrad degrees. If you don’t want to be saddled with debt, go where you can afford to go. Live within your means. You never hear the phrase “broke college student” anymore! If you have to borrow, borrow the least amount necessary. Take it semester by semester. It may take you more than 4 years to graduate & that’s ok! And, get a job! You may graduate with some debt, but it won’t be crippling!
Women deserve FDA-approved testosterone therapies grounded in modern science — with standardized dosing, insurance coverage, and long-term safety guidelines.
The evidence is here.
The medical need is clear.
What’s missing is regulatory action.
#WomensHealth#HormoneHealth #MenopauseCare #HRT #EvidenceBasedMedicine #ClinicalResearch #TestosteroneForWomen
Women suffering symptoms of perimenopause/menopause deserve access to safe, evidence-based hormone therapy.
Testosterone treatment has been genuinely life-changing for me—restoring quality of life when nothing else helped. Yet there is still no FDA-approved testosterone option for women, and many therapies remain uncovered by insurance.
It’s time to prioritize research, updated guidelines, and thoughtful regulation so women can receive the care they truly need.
#WomensHealth #HRT #MenopauseCare #HormoneHealth #BioidenticalHormones
@HHSGov@US_FDA@FDAWomen@NIH_ORWH@SenTedCruz@JohnCornyn @RepJodeyArrington
Yet because the FDA has never approved a formulation designed for women, most must rely on:
• off-label dosing of male products
• compounded preparations
• inconsistent coverage
This regulatory gap reduces access to safe, standardized, affordable care.
Major medical societies agree that testosterone has validated use in women when clinically indicated:
• International Society for the Study of Women’s Sexual Health (ISSWSH)
• Endocrine Society
• North American Menopause Society (NAMS)
All support carefully monitored, evidence-based therapy.
Sexual function is one area of benefit — well documented in studies like Davis et al., NEJM 2008 — but it is not the only or even the primary impact for many women.
The broader health effects are clinically significant and often overlooked.
Quality-of-life improvements are consistently documented.
A meta-analysis in JAMA Network Open (Islam et al., 2019) across 36 trials found women experienced:
• higher energy levels
• improved mood
• better daily functioning
• improved sense of well-being
No increase in serious adverse events at physiologic doses.
Metabolism and energy regulation are also affected.
• Haring et al., Diabetes Care 2012: Low testosterone in women correlated with higher insulin resistance and metabolic syndrome risk.
• Utriainen et al., Eur J Endocrinol 1996: Testosterone influences glucose utilization and mitochondrial energy production.